SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-22-018443
Filing Date
2022-04-06
Accepted
2022-04-06 16:31:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ea157963-posam_180life.htm POS AM 35059
2 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea157963ex23-1_180life.htm EX-23.1 2091
  Complete submission text file 0001213900-22-018443.txt   38206
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-259209 | Film No.: 22810943
SIC: 2834 Pharmaceutical Preparations